January 31, 2023

Volume XIII, Number 31

2021 Japan Seminar Session 4: US Healthcare Market Lecture for Japanese Businesses and Investors– Part 2

Our 9th McDermott International Japan Seminar will be held as a virtual series, with eight sessions taking place between January 21 – February 4, 2021. Though we cannot see you in person, we didn't want to miss the opportunity to connect with you on the latest legal topics affecting Japanese companies.

The virtual event series will explore US trade policy, global mergers and acquisitions, the US healthcare market, intellectual property, international data privacy / cybersecurity, white collar enforcement and cross border compliance related topics, with a significant focus on what Japanese companies can expect from the Biden Administration.

Our McDermott panelists not only include our seasoned lawyers on Japanese business issues, but also Dean Pinkert, a former commissioner of the US International Trade Commission, nominated by President George W. Bush and confirmed by the US Senate in 2007, and Caitlyn Campbell, a former US Securities & Exchange Commission (SEC) Enforcement Attorney, and several other former government officials and prosecutors.

Join us for what promises to be an engaging series as we dig into the issues at hand and highlight what to consider next for your business.

In this episode we cover part 2 of the overview of the US healthcare system for Japanese companies and investors. 

Part Two will provide a practical, real-world discussion outlining key considerations for entering into the US healthcare market. We will:   

  • Work through case studies that illustrate the unique regulatory issues entities involved in the delivery of health care services face in the US
  • Provide real-world, practical advice to facilitate the navigation of regulatory issues without jeopardizing key business objectives
  • Explore implications for stakeholders such as payors, providers, life sciences companies, infrastructure providers ( eg , electronic health records, developers, other vendors), and patients and consumers